[A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation]
- PMID: 9546133
[A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation]
Abstract
A 59-year-old man was diagnosed with clinical stage D1 poorly differentiated prostatic adenocarcinoma (PAC). The patient was treated with total androgen blockade therapy. The tumor recurred 18 months later. Digital rectal examination revealed a large, stony-hard prostate. The serum PSA level was within normal limits. Pathological examination of the prostate revealed conventional adenocarcinoma with large numbers of neuroendocrine (NE) cells. The patient died 3 months after the diagnosis of PAC with NE differentiation, 22 months after the initial diagnosis of prostate cancer.
Similar articles
-
[A case of prostate cancer treated with combined androgen-blockade].Gan To Kagaku Ryoho. 2000 Feb;27(2):307-10. Gan To Kagaku Ryoho. 2000. PMID: 10700907 Japanese.
-
[Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].Hinyokika Kiyo. 2004 Nov;50(11):813-5. Hinyokika Kiyo. 2004. PMID: 15628545 Japanese.
-
[Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].Hinyokika Kiyo. 2010 Jan;56(1):49-54. Hinyokika Kiyo. 2010. PMID: 20104011 Review. Japanese.
-
[Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].Hinyokika Kiyo. 2005 Jan;51(1):33-5. Hinyokika Kiyo. 2005. PMID: 15732339 Japanese.
-
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.J Endocrinol Invest. 2005;28(11 Suppl International):141-5. J Endocrinol Invest. 2005. PMID: 16625864 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous